Switzerland· 67352002
Spiolto Respimat 2.5 mcg / 2.5 mcg, Lösung zur Inhalation (wiederverwendbar)
A olodaterol und tiotropium bromid product containing tiotropium, olodaterolum, registered in Switzerland by Boehringer Ingelheim (Schweiz) GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Olodaterol und tiotropium bromid is registered in 10 of 19 countries.
Countries holding a registration under ATC R03AL06 (olodaterol und tiotropium bromid), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Olodaterol und tiotropium bromid · ATC R03AL06
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- tiotropium, olodaterolum
- Manufacturer
- Boehringer Ingelheim (Schweiz) GmbH
- Country
- Switzerland (CH)
- ATC code
- R03AL06
- ATC class
- Olodaterol und Tiotropium bromid
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76806735200243 Dosierspr 60 DosCHF 162.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olodaterol und tiotropium bromid in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSPIOLTO RESPIMATBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- NetherlandsSpiolto Respimat 2,5 microgram/2,5 microgram, inhalatieoplossingBoehringer Ingelheim International GmbH
- SpainSPIOLTO RESPIMAT 2,5 MICROGRAMOS / 2,5 MICROGRAMOS SOLUCION PARA INHALACIONBoehringer Ingelheim International Gmbh
- IrelandSpiolto Respimat 2.5 microgram/2.5 microgram, inhalation solutionBoehringer Ingelheim International GmbH
- United KingdomSpiolto Respimat 2.5micrograms/dose / 2.5micrograms/dose inhalation solution cartridge with deviceBoehringer Ingelheim Ltd
- FinlandInspiolto RespimatBoehringer Ingelheim International GmbH
- GermanySpiolto RespimatBoehringer Ingelheim International Gmbh
- PolandSpiolto RespimatBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Spiolto Respimat, Yanimo Respimat
- Belgium · Spiolto Respimat, Yanimo Respimat
- Bulgaria · Спиолто Респимат, Янимо Респимат
- Cyprus · Spiolto Respimat, Yanimo Respimat
- Czechia · Spiolto Respimat
- Germany · Spiolto Respimat, Yanimo Respimat
- Denmark · Spiolto Respimat
- Estonia · Spiolto Respimat
- Spain · Spiolto Respimat, Yanimo Respimat
- Finland · Inspiolto Respimat, Yanimo Respimat
- France · Spiolto Respimat
- United Kingdom (Northern Ireland) · Spiolto Respimat
- Greece · Spiolto Respimat, Yanimo Respimat
- Croatia · Spiolto Respimat
- Hungary · Spiolto Respimat
- Ireland · Spiolto Respimat
- Iceland · Spiolto Respimat
- Italy · Spiolto Respimat
- Liechtenstein · Spiolto Respimat, Yanimo Respimat
- Lithuania · Spiolto Respimat
- Luxembourg · Spiolto Respimat, Yanimo Respimat
- Latvia · Spiolto Respimat
- Malta · Spiolto Respimat
- Netherlands · Spiolto Respimat, Yanimo Respimat
- Norway · Spiolto Respimat
- Poland · Spiolto Respimat, Yanimo Respimat
- Portugal · Spiolto Respimat, Yanimo Respimat
- Romania · Spiolto Respimat
- Sweden · Spiolto Respimat, Yanimo Respimat
- Slovenia · Spiolto Respimat
- Slovakia · Spiolto Respimat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f271ba9b-e593-47b6-a06b-99ec319d8234 GET /v1/drugs/f271ba9b-e593-47b6-a06b-99ec319d8234?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "tiotropium 2.5 mcg + olodaterolum 2.5 mcg",
"valid_from": "2019-11-01",
"limitations": null,
"galenic_form": "Inhal Lös 2.5 mcg/Hub wiederverw",
"therapeutic_area": null,
"sl_inclusion_date": "2019-11-01",
"self_retention_pct": 10
}See everything about olodaterol und tiotropium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.